Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: Results from an Italian multicentre study

Riccardo Bomben, Michele Dal Bo, Daniela Capello, Francesco Forconi, Rossana Maffei, Luca Laurenti, Davide Rossi, Maria Ilaria Del Principe, Antonella Zucchetto, Francesco Bertoni, Francesca Maria Rossi, Pietro Bulian, Ilaria Cattarossi, Fiorella Ilariucci, Elisa Sozzi, Valeria Spina, Emanuele Zucca, Massimo Degan, Francesco Lauria, Giovanni Del PoetaDimitar G. Efremov, Roberto Marasca, Gianluca Gaidano, Valter Gattei

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

A fraction of chronic lymphocytic leukaemia (CLL) cases carry highly homologous B-cell receptors (BCR), i.e. characterized by non-random combinations of immunoglobulin heavy-chain variable (IGHV) genes and heavy-chain complementarity determining region-3 (HCDR3), often associated with a restricted selection of IGVK/L light chains. Such 'stereotyped' BCR occur more frequently in CLL with unmutated (UM) than mutated (M) IGHV genes. We analysed 1426 IG rearrangements (from 1398 CLL cases) by a clustering driven by HCDR3 similarities. Molecular findings were correlated to time-to-treatment (TTT) and presence of known prognosticators. Sixty-nine clusters (319 IG-rearrangements, 22.4%) with stereotyped BCR were identified. Among 30 confirmed clusters (≥3 IG-rearrangements/cluster), we found 14 novel clusters, of which 11 had M IG rearrangements (M clusters) and predominantly (8/11) used IGHV3 subgroup genes. Recurrent cluster-biased amino acid changes were found throughout IGHV sequences of these 'M clusters'. Regarding clinical outcome: (i) UM CLL from the IGHV1-2/1-3/1-18/1-46/7-4-1/IGKV1-39 cluster had poorer prognosis than UM/M cases, or UM cases using the same IGHV genes but not in clusters; (ii) M CLL from the IGHV3-21/IGLV3-21 cluster had TTT similar to UM CLL, and shorter than M CLL expressing IGHV3-21 but not in cluster. Altogether, our analysis identified additional molecular and clinical features for CLL expressing stereotyped BCR.

Original languageEnglish
Pages (from-to)492-506
Number of pages15
JournalBritish Journal of Haematology
Volume144
Issue number4
DOIs
Publication statusPublished - Feb 2009

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
Multicenter Studies
B-Lymphocytes
Immunoglobulin Heavy Chain Genes
Complementarity Determining Regions
Immunoglobulin Heavy Chains
Cluster Analysis
Light
Amino Acids
Genes

Keywords

  • B cell receptor
  • Chronic lymphocytic leukaemia
  • Immunoglobulin genes
  • Prognosis

ASJC Scopus subject areas

  • Hematology

Cite this

Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors : Results from an Italian multicentre study. / Bomben, Riccardo; Dal Bo, Michele; Capello, Daniela; Forconi, Francesco; Maffei, Rossana; Laurenti, Luca; Rossi, Davide; Del Principe, Maria Ilaria; Zucchetto, Antonella; Bertoni, Francesco; Rossi, Francesca Maria; Bulian, Pietro; Cattarossi, Ilaria; Ilariucci, Fiorella; Sozzi, Elisa; Spina, Valeria; Zucca, Emanuele; Degan, Massimo; Lauria, Francesco; Del Poeta, Giovanni; Efremov, Dimitar G.; Marasca, Roberto; Gaidano, Gianluca; Gattei, Valter.

In: British Journal of Haematology, Vol. 144, No. 4, 02.2009, p. 492-506.

Research output: Contribution to journalArticle

Bomben, R, Dal Bo, M, Capello, D, Forconi, F, Maffei, R, Laurenti, L, Rossi, D, Del Principe, MI, Zucchetto, A, Bertoni, F, Rossi, FM, Bulian, P, Cattarossi, I, Ilariucci, F, Sozzi, E, Spina, V, Zucca, E, Degan, M, Lauria, F, Del Poeta, G, Efremov, DG, Marasca, R, Gaidano, G & Gattei, V 2009, 'Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: Results from an Italian multicentre study', British Journal of Haematology, vol. 144, no. 4, pp. 492-506. https://doi.org/10.1111/j.1365-2141.2008.07469.x
Bomben, Riccardo ; Dal Bo, Michele ; Capello, Daniela ; Forconi, Francesco ; Maffei, Rossana ; Laurenti, Luca ; Rossi, Davide ; Del Principe, Maria Ilaria ; Zucchetto, Antonella ; Bertoni, Francesco ; Rossi, Francesca Maria ; Bulian, Pietro ; Cattarossi, Ilaria ; Ilariucci, Fiorella ; Sozzi, Elisa ; Spina, Valeria ; Zucca, Emanuele ; Degan, Massimo ; Lauria, Francesco ; Del Poeta, Giovanni ; Efremov, Dimitar G. ; Marasca, Roberto ; Gaidano, Gianluca ; Gattei, Valter. / Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors : Results from an Italian multicentre study. In: British Journal of Haematology. 2009 ; Vol. 144, No. 4. pp. 492-506.
@article{fdbbd64868094277a2b991a7a6959cb9,
title = "Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: Results from an Italian multicentre study",
abstract = "A fraction of chronic lymphocytic leukaemia (CLL) cases carry highly homologous B-cell receptors (BCR), i.e. characterized by non-random combinations of immunoglobulin heavy-chain variable (IGHV) genes and heavy-chain complementarity determining region-3 (HCDR3), often associated with a restricted selection of IGVK/L light chains. Such 'stereotyped' BCR occur more frequently in CLL with unmutated (UM) than mutated (M) IGHV genes. We analysed 1426 IG rearrangements (from 1398 CLL cases) by a clustering driven by HCDR3 similarities. Molecular findings were correlated to time-to-treatment (TTT) and presence of known prognosticators. Sixty-nine clusters (319 IG-rearrangements, 22.4{\%}) with stereotyped BCR were identified. Among 30 confirmed clusters (≥3 IG-rearrangements/cluster), we found 14 novel clusters, of which 11 had M IG rearrangements (M clusters) and predominantly (8/11) used IGHV3 subgroup genes. Recurrent cluster-biased amino acid changes were found throughout IGHV sequences of these 'M clusters'. Regarding clinical outcome: (i) UM CLL from the IGHV1-2/1-3/1-18/1-46/7-4-1/IGKV1-39 cluster had poorer prognosis than UM/M cases, or UM cases using the same IGHV genes but not in clusters; (ii) M CLL from the IGHV3-21/IGLV3-21 cluster had TTT similar to UM CLL, and shorter than M CLL expressing IGHV3-21 but not in cluster. Altogether, our analysis identified additional molecular and clinical features for CLL expressing stereotyped BCR.",
keywords = "B cell receptor, Chronic lymphocytic leukaemia, Immunoglobulin genes, Prognosis",
author = "Riccardo Bomben and {Dal Bo}, Michele and Daniela Capello and Francesco Forconi and Rossana Maffei and Luca Laurenti and Davide Rossi and {Del Principe}, {Maria Ilaria} and Antonella Zucchetto and Francesco Bertoni and Rossi, {Francesca Maria} and Pietro Bulian and Ilaria Cattarossi and Fiorella Ilariucci and Elisa Sozzi and Valeria Spina and Emanuele Zucca and Massimo Degan and Francesco Lauria and {Del Poeta}, Giovanni and Efremov, {Dimitar G.} and Roberto Marasca and Gianluca Gaidano and Valter Gattei",
year = "2009",
month = "2",
doi = "10.1111/j.1365-2141.2008.07469.x",
language = "English",
volume = "144",
pages = "492--506",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley & Sons, Ltd (10.1111)",
number = "4",

}

TY - JOUR

T1 - Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors

T2 - Results from an Italian multicentre study

AU - Bomben, Riccardo

AU - Dal Bo, Michele

AU - Capello, Daniela

AU - Forconi, Francesco

AU - Maffei, Rossana

AU - Laurenti, Luca

AU - Rossi, Davide

AU - Del Principe, Maria Ilaria

AU - Zucchetto, Antonella

AU - Bertoni, Francesco

AU - Rossi, Francesca Maria

AU - Bulian, Pietro

AU - Cattarossi, Ilaria

AU - Ilariucci, Fiorella

AU - Sozzi, Elisa

AU - Spina, Valeria

AU - Zucca, Emanuele

AU - Degan, Massimo

AU - Lauria, Francesco

AU - Del Poeta, Giovanni

AU - Efremov, Dimitar G.

AU - Marasca, Roberto

AU - Gaidano, Gianluca

AU - Gattei, Valter

PY - 2009/2

Y1 - 2009/2

N2 - A fraction of chronic lymphocytic leukaemia (CLL) cases carry highly homologous B-cell receptors (BCR), i.e. characterized by non-random combinations of immunoglobulin heavy-chain variable (IGHV) genes and heavy-chain complementarity determining region-3 (HCDR3), often associated with a restricted selection of IGVK/L light chains. Such 'stereotyped' BCR occur more frequently in CLL with unmutated (UM) than mutated (M) IGHV genes. We analysed 1426 IG rearrangements (from 1398 CLL cases) by a clustering driven by HCDR3 similarities. Molecular findings were correlated to time-to-treatment (TTT) and presence of known prognosticators. Sixty-nine clusters (319 IG-rearrangements, 22.4%) with stereotyped BCR were identified. Among 30 confirmed clusters (≥3 IG-rearrangements/cluster), we found 14 novel clusters, of which 11 had M IG rearrangements (M clusters) and predominantly (8/11) used IGHV3 subgroup genes. Recurrent cluster-biased amino acid changes were found throughout IGHV sequences of these 'M clusters'. Regarding clinical outcome: (i) UM CLL from the IGHV1-2/1-3/1-18/1-46/7-4-1/IGKV1-39 cluster had poorer prognosis than UM/M cases, or UM cases using the same IGHV genes but not in clusters; (ii) M CLL from the IGHV3-21/IGLV3-21 cluster had TTT similar to UM CLL, and shorter than M CLL expressing IGHV3-21 but not in cluster. Altogether, our analysis identified additional molecular and clinical features for CLL expressing stereotyped BCR.

AB - A fraction of chronic lymphocytic leukaemia (CLL) cases carry highly homologous B-cell receptors (BCR), i.e. characterized by non-random combinations of immunoglobulin heavy-chain variable (IGHV) genes and heavy-chain complementarity determining region-3 (HCDR3), often associated with a restricted selection of IGVK/L light chains. Such 'stereotyped' BCR occur more frequently in CLL with unmutated (UM) than mutated (M) IGHV genes. We analysed 1426 IG rearrangements (from 1398 CLL cases) by a clustering driven by HCDR3 similarities. Molecular findings were correlated to time-to-treatment (TTT) and presence of known prognosticators. Sixty-nine clusters (319 IG-rearrangements, 22.4%) with stereotyped BCR were identified. Among 30 confirmed clusters (≥3 IG-rearrangements/cluster), we found 14 novel clusters, of which 11 had M IG rearrangements (M clusters) and predominantly (8/11) used IGHV3 subgroup genes. Recurrent cluster-biased amino acid changes were found throughout IGHV sequences of these 'M clusters'. Regarding clinical outcome: (i) UM CLL from the IGHV1-2/1-3/1-18/1-46/7-4-1/IGKV1-39 cluster had poorer prognosis than UM/M cases, or UM cases using the same IGHV genes but not in clusters; (ii) M CLL from the IGHV3-21/IGLV3-21 cluster had TTT similar to UM CLL, and shorter than M CLL expressing IGHV3-21 but not in cluster. Altogether, our analysis identified additional molecular and clinical features for CLL expressing stereotyped BCR.

KW - B cell receptor

KW - Chronic lymphocytic leukaemia

KW - Immunoglobulin genes

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=58549100059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58549100059&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2008.07469.x

DO - 10.1111/j.1365-2141.2008.07469.x

M3 - Article

C2 - 19036101

AN - SCOPUS:58549100059

VL - 144

SP - 492

EP - 506

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 4

ER -